Twelve polyphenol derivatives were obtained in a protective activity-guided isolation from the Portulaca oleracea L. extract on a cell model of human umbilical vein endothelial cells (HUVECs) under diethylhexyl phthalate (DEHP) exposure. Among them, methyl (3,4,5-trimethoxybenzoyl) valylprolinate (PP-10) performed the most protective activity and inhibited DEHP exposure-induced HUVECs’ apoptosis. PP-10 also inhibited the DEHP-induced inflammatory cytokines (TNF-α, IL-6, IL-1β, and IL-8) and adhesion molecule (ICAM-1 andVCAM-1) overexpression. Furthermore, DEHP-induced NLRP3 inflammasomes’ and NF-κB signaling pathway activation was significantly inhibited after the PP-10 treatments. Of note, the current results suggest the potential application of Portulaca oleracea L. and PP-10 in the prevention of DEHP-induced inflammatory damages in HUVECs.
Get full access to this article
View all access options for this article.
References
1.
SteinbergD. Hypercholesterolemia and inflammation in atherogenesis: Two sides of the same coin. Mol Nutr Food Res, 2005; 49(11):995–998.
2.
KuehnBM. Environmental pollutants tied to atherosclerosis. Jama-J Am Med Assoc, 2011; 306(19):2081–2081.
3.
PicheC, LeaskR, RobaireB. The testicular toxicity and disruption of steroidogenesis by the plasticizer di-(2-ethylhexyl) phthalate and four of its metabolites. Toxicol Lett, 2008; 180:S56.
4.
TetzLM, AronoffDM, Loch-CarusoR. Mono-ethylhexyl phthalate stimulates prostaglandin secretion in human placental macrophages and THP-1 cells. Reprod Biol Endocrin, 2015; 13.
5.
ContrerasTJ, SheibleyRH, ValeriCR. Accumulation of DI-2-ethylhexyl phthalate (DEHP) in whole blood, platelet concentrates, and platelet-poor plasma. Transfusion, 1974; 14(1):34–46.
6.
ShihMF, PanKH, LiuCC, et al.Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression. Regul Toxicol Pharmacol, 2018; 92:333–337.
7.
AlamMA, JuraimiAS, RafiiMY, et al.Genetic improvement of purslane (Portulaca oleracea L.) and its future prospects. Mol Biol Rep, 2014; 41(11):7395–7411.
8.
GhoraniV, SaadatS, KhazdairMR, et al.Phytochemical characteristics and anti-inflammatory, immunoregulatory, and antioxidant effects of portulaca oleracea L: A comprehensive review. Evid Based Complement Alternat Med, 2023; 2023:2075444.
9.
ChanK, IslamMW, KamilM, et al.The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp sativa (Haw.) Celak. J Ethnopharmacol, 2000; 73(3):445–451.
10.
EidiA, MortazaviP, MoghadamJZ, et al.Hepatoprotective effects of Portulaca oleracea extract against CCl4-induced damage in rats. Pharm Biol, 2015; 53(7):1042–1051.
11.
ZhaoR, GaoX, CaiYP, et al.Antitumor activity of Portulaca oleracea L. Polysaccharides against cervical carcinoma in vitro and in vivo. Carbohydr Polym, 2013; 96(2):376–383.
12.
ZhuHB, WangYZ, LiuYX, et al.Analysis of flavonoids in portulaca oleracea L. by UV-Vis spectrophotometry with comparative study on different extraction technologies. Food Anal Methods, 2010; 3(2):90–97.
13.
ZhouYX, XinHL, RahmanK, et al.Portulaca oleracea L.: A review of phytochemistry and pharmacological effects. Biomed Res Int, 2015; 2015:925631.
14.
LanXJ, GuoSN, ZhaoYD, et al.A novel skeleton alkaloid from Portulaca oleracea L. And its bioactivities. Fitoterapia, 2023; 169:105608.
15.
YangZJ, LiuCJ, XiangL, et al.Phenolic alkaloids as a new class of antioxidants in portulaca oleracea. Phytother Res, 2009; 23(7):1032–1035.
16.
ZhaoR, ZhangT, MaB, et al.Antitumor activity of portulaca oleracea L. Polysaccharide on Hela cells through inducing TLR4/NF-κB signaling. Nutr Cancer, 2017; 69(1):131–139.
17.
WojdasiewiczP, PoniatowskiLA, SzukiewiczD. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm, 2014; 2014:1–19.
18.
ErkekogluP, ZeybekND, GirayB, et al.The effects of Di(2-Ethylhexyl) phthalate exposure and selenium nutrition on sertoli cell vimentin structure and germ-cell apoptosis in rat testis. Arch Environ Contam Toxicol, 2012; 62(3):539–547.
19.
ZahranEM, NewA, GavalasV, et al.Polymeric plasticizer extends the lifetime of PVC-membrane ion-selective electrodes. Analyst, 2014; 139(4):757–763.
20.
ZouQY, HongSL, KangHY, et al.Effect of di-(2-ethylhexyl) phthalate (DEHP) on allergic rhinitis. Sci Rep, 2020; 10(1):14625.
21.
SakthivelKM, GuruvayoorappanC. Acacia ferruginea inhibits tumor progression by regulating inflammatory mediators-(TNF-a, iNOS, COX-2, IL-1β, IL-6, IFN-γ, IL-2, GM-CSF) and pro-angiogenic growth factor-VEGF. Asian Pac J Cancer Prev, 2013; 14(6):3909–3919.
22.
LiZ, ClarkJ, DiehlAM. The liver in obesity and type 2 diabetes mellitus. Clin Liver Dis, 2002; 6(4):867–877.
23.
YoonWJ, HamYM, YooBS, et al.Oenothera laciniata inhibits lipopolysaccharide induced production of nitric oxide, prostaglandin E2, and proinflammatory cytokines in RAW264.7 macrophages. J Biosci Bioeng, 2009; 107(4):429–438.
24.
TanakaK, SuemasuS, IshiharaT, et al.Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis. Eur J Pharmacol, 2009; 603(1–3):120–132.
25.
QiaoY, WangP, QiJ, et al.TLR-induced NF-κB activation regulates NLRP3 expression in murine macrophages. FEBS Lett, 2012; 586(7):1022–1026.
26.
EnesaK, ZakkarM, ChaudhuryH, et al.NF-kappaB suppression by the deubiquitinating enzyme Cezanne: A novel negative feedback loop in pro-inflammatory signaling. J Biol Chem, 2008; 283(11):7036–7045.
27.
CullenSP, KearneyCJ, ClancyDM, et al.Diverse activators of the NLRP3 inflammasome promote IL-1β secretion by triggering necrosis. Cell Rep, 2015; 11(10):1535–1548.
28.
KimNH, KimHK, LeeJH, et al.Juglone suppresses LPS-induced inflammatory responses and NLRP3 activation in macrophages. Molecules, 2020; 25(13).
